This mechanism of MYB regulation is of potential relevance to MLL fusion-driven AML because several MLL fusion partners including AF9, ENL, AF4 and AF5q31, are members of the SEC/EAP multi-protein complex19–21 which also contains pTEFb. The gene discussed is MLLT3; the disease is acute myeloid leukemia.